Y Intercept Hong Kong Ltd Makes New $1.56 Million Investment in Addus HomeCare Corporation $ADUS

Y Intercept Hong Kong Ltd bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 16,688 shares of the company’s stock, valued at approximately $1,563,000.

A number of other large investors also recently made changes to their positions in the stock. Global Retirement Partners LLC grew its stake in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC lifted its stake in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares during the period. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare during the fourth quarter worth about $29,000. Private Trust Co. NA boosted its holdings in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the last quarter. Finally, Arax Advisory Partners boosted its holdings in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ADUS shares. Barclays upped their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday. Citizens Jmp reissued a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Weiss Ratings cut shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. Finally, Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.50.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 966 shares of company stock valued at $90,168. Company insiders own 4.10% of the company’s stock.

Addus HomeCare Stock Up 3.2%

ADUS stock opened at $109.72 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. The stock has a market capitalization of $2.05 billion, a P/E ratio of 20.28, a P/E/G ratio of 1.46 and a beta of 0.88. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The business has a 50-day moving average of $95.91 and a 200-day moving average of $101.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same period in the previous year, the business earned $1.42 EPS. The company’s revenue was up 7.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.